PDCD1 and Epstein-Barr virus infection: Combination treatment with CV8102 and anti-PD-1 antibodies increased the upregulation of these gene sets and induced additional gene sets associated with TNF signaling, cytosolic-DNA-sensing and Epstein-Barr virus infection, indicating a synergistic effect of anti-PD-1 treatment with CV8102.